# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-001696
Filing Date
2018-02-09
Accepted
2018-02-08 20:58:29
Documents
53
Period of Report
2017-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm | 10-Q | 755038
2 |  | ex31-1.htm | EX-31.1 | 15319
3 |  | ex32-1.htm | EX-32.1 | 7310
| Complete submission text file | 0001493152-18-001696.txt |  | 5746038

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | ppcb-20171231.xml | EX-101.INS | 783800
5 | XBRL SCHEMA FILE | ppcb-20171231.xsd | EX-101.SCH | 59091
6 | XBRL CALCULATION FILE | ppcb-20171231_cal.xml | EX-101.CAL | 51567
7 | XBRL DEFINITION FILE | ppcb-20171231_def.xml | EX-101.DEF | 235184
8 | XBRL LABEL FILE | ppcb-20171231_lab.xml | EX-101.LAB | 385711
9 | XBRL PRESENTATION FILE | ppcb-20171231_pre.xml | EX-101.PRE | 290268

Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 18587406
SIC: 2834 Pharmaceutical Preparations